atorvastatin has been researched along with Anemia, Sickle Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archer, DR; Ataga, KI; Cai, J; Caughey, MC; Derebail, VK; Elsherif, L; Hinderliter, AL; Maitra, P; Pollock, DM; Pollock, JS; Wichlan, D; Wogu, AF | 1 |
| Archer, DR; Ataga, KI; Brown, LA; Chappa, P; Yin, H; Zahr, RS | 1 |
| Bereal-Williams, C; Cannon, RO; Chi, A; Dalby, CK; Hauser, KP; Hunter, CJ; Hunter, L; Kato, GJ; Machado, RF; McGowan, V; Tailor, A | 1 |
2 trial(s) available for atorvastatin and Anemia, Sickle Cell
| Article | Year |
|---|---|
A pilot study of the effect of atorvastatin on endothelial function and albuminuria in sickle cell disease.
Topics: Aged; Albuminuria; Anemia, Sickle Cell; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; beta-Thalassemia; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxyurea; Male; Middle Aged; Pilot Projects; Renal Circulation; Renal Insufficiency, Chronic; Sickle Cell Trait | 2019 |
Atorvastatin reduces serum cholesterol and triglycerides with limited improvement in vascular function in adults with sickle cell anemia.
Topics: Adult; Anemia, Sickle Cell; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cohort Studies; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Pyrroles | 2012 |
1 other study(ies) available for atorvastatin and Anemia, Sickle Cell
| Article | Year |
|---|---|
Renal protection by atorvastatin in a murine model of sickle cell nephropathy.
Topics: Anemia, Sickle Cell; Animals; Atorvastatin; Disease Models, Animal; Female; Kidney; Kidney Diseases; Male; Mice; Mice, Mutant Strains; NADPH Oxidase 2; NADPH Oxidase 4 | 2018 |